4//SEC Filing
Actinium Pharmaceuticals, Inc. 4
Accession 0001213900-15-004133
$ATNMCIK 0001388320operating
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:07 PM ET
Size
8.8 KB
Accession
0001213900-15-004133
Insider Transaction Report
Form 4
CICIC DRAGAN
COO and CMO
Transactions
- Tax Payment
Common stock
2015-05-07$2.52/sh−560$1,411→ 560 total - Award
Options to purchase common stock
2015-05-07$2.52/sh+2,874$7,242→ 2,874 totalExercise: $2.52From: 2015-05-07Exp: 2025-05-07→ Common stock (2,874 underlying) - Disposition to Issuer
Common stock
2015-05-07$2.52/sh−2,380$5,998→ 560 total
Footnotes (1)
- [F1]Recipient was granted 3,500 shares of restricted common stock on 2/21/14. As of May 7, 2015, 1,120 shares were vested. Company withheld 560 shares to pay tax obligations of award recipient on vested shares. The remaining 2,380 unvested shares of restricted stock were cancelled and a new award of 2,874 options exercisable for shares of common stock were granted to the recipient.
Documents
Issuer
Actinium Pharmaceuticals, Inc.
CIK 0001388320
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001388320
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 5:07 PM ET
- Size
- 8.8 KB